Pharmaceuticals

GW Pharmaceuticals Commences Phase 1 Clinical Trial of GWP42006 as a Potential Treatment for Epilepsy
Breaking News

0

London, UK; 18 September 2013: GW Pharmaceuticals plc (GWPH) announced today it has commenced a Phase 1 clinical trial of product candidate GWP42006 for the treatment of epilepsy.

Acura Pharmaceuticals Soars for a Second Day; A Comprehensive Look at the Stock
Stocks

0

Shares of small-cap biotech company Acura Pharmaceuticals (ACUR, quote) soared once again on Tuesday after a massive rally in the name during Monday’s trading session. The stock surged 42 percent and closed the day at $3.49. Acura opened the session at $2.49 and traded all the way up to $4.50 at one point in the morning.